File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Book Chapter: Ankyrin Repeat and Suppressor of Cytokine Signaling Box (ASB) Family Members for Cancer Diagnosis, Prognosis, and Treatment

TitleAnkyrin Repeat and Suppressor of Cytokine Signaling Box (ASB) Family Members for Cancer Diagnosis, Prognosis, and Treatment
Authors
KeywordsASB
Hepatocellular carcinoma
Protein degradation
SOCS box
Tumorigenesis
Ubiquitination
Issue Date2013
PublisherHumana Press
Citation
Ankyrin Repeat and Suppressor of Cytokine Signaling Box (ASB) Family Members for Cancer Diagnosis, Prognosis, and Treatment. In Lee, NP ... (et al) (Eds.), New Advances on Disease Biomarkers and Molecular Targets in Biomedicine, p. 27-37. New York: Humana Press, 2013 How to Cite?
AbstractAnkyrin repeat and suppressor of cytokine signaling box (ASB) protein family consists of 18 members. Functional domains composing of ankyrin repeat domain and SOCS box are two distinct features found associating with members of ASB family. The major function of ASBs is believed to be involving in proteasomal-mediated protein degradation, in which ASBs act as subunits of the E3 complexes in the ubiquitination process. Research on ASB family further reveals that some members of the ASB family are involving in physiological and even oncological processes. For cancers, ASB family members involve in a panel of cancers, including nasopharyngeal carcinoma, lung carcinoma, and hepatocellular carcinoma. It is believed that the regulatory effect of each ASB is probably determined by the proteins that they targeted for proteasomal degradation, for instance, targeting oncogenes for tumor suppression and targeting tumor suppressors for tumor promotion. Apart from cancers, other members are discovered involving in various cellular processes, from angiogenesis to regulation of differentiation. Still, there are several ASBs with no defined functions. Further studies are therefore necessary to decipher the roles of these ASBs regarding their potential involvements in physiological and pathological processes.
Persistent Identifierhttp://hdl.handle.net/10722/196601
ISBN

 

DC FieldValueLanguage
dc.contributor.authorAu, CHVen_US
dc.contributor.authorLee, NPYen_US
dc.date.accessioned2014-04-22T08:40:41Z-
dc.date.available2014-04-22T08:40:41Z-
dc.date.issued2013en_US
dc.identifier.citationAnkyrin Repeat and Suppressor of Cytokine Signaling Box (ASB) Family Members for Cancer Diagnosis, Prognosis, and Treatment. In Lee, NP ... (et al) (Eds.), New Advances on Disease Biomarkers and Molecular Targets in Biomedicine, p. 27-37. New York: Humana Press, 2013en_US
dc.identifier.isbn9781627034555en_US
dc.identifier.urihttp://hdl.handle.net/10722/196601-
dc.description.abstractAnkyrin repeat and suppressor of cytokine signaling box (ASB) protein family consists of 18 members. Functional domains composing of ankyrin repeat domain and SOCS box are two distinct features found associating with members of ASB family. The major function of ASBs is believed to be involving in proteasomal-mediated protein degradation, in which ASBs act as subunits of the E3 complexes in the ubiquitination process. Research on ASB family further reveals that some members of the ASB family are involving in physiological and even oncological processes. For cancers, ASB family members involve in a panel of cancers, including nasopharyngeal carcinoma, lung carcinoma, and hepatocellular carcinoma. It is believed that the regulatory effect of each ASB is probably determined by the proteins that they targeted for proteasomal degradation, for instance, targeting oncogenes for tumor suppression and targeting tumor suppressors for tumor promotion. Apart from cancers, other members are discovered involving in various cellular processes, from angiogenesis to regulation of differentiation. Still, there are several ASBs with no defined functions. Further studies are therefore necessary to decipher the roles of these ASBs regarding their potential involvements in physiological and pathological processes.-
dc.languageengen_US
dc.publisherHumana Pressen_US
dc.relation.ispartofNew Advances on Disease Biomarkers and Molecular Targets in Biomedicineen_US
dc.subjectASB-
dc.subjectHepatocellular carcinoma-
dc.subjectProtein degradation-
dc.subjectSOCS box-
dc.subjectTumorigenesis-
dc.subjectUbiquitination-
dc.titleAnkyrin Repeat and Suppressor of Cytokine Signaling Box (ASB) Family Members for Cancer Diagnosis, Prognosis, and Treatmenten_US
dc.typeBook_Chapteren_US
dc.identifier.emailLee, NPY: nikkilee@hku.hken_US
dc.identifier.authorityLee, NPY=rp00263en_US
dc.identifier.doi10.1007/978-1-62703-456-2_2-
dc.identifier.scopuseid_2-s2.0-84929909476-
dc.identifier.hkuros228557en_US
dc.identifier.spage27-
dc.identifier.epage37-
dc.publisher.placeNew York-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats